While in papillary RCC, the immunoreactivity was as follows: AMACR, 95%; CK7, 65%; EMA, 88%; RCC Ma, 25%; CD10, 80%; HWMK, 15%; and c-kit, 18%. This evidence concerns the gene KIT and renal cell carcinoma.